SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

S2 - Neuroimaging in MS

Event Time: Sunday April 23, 2017 1:00 pm to 3:00 pm
Topic(s): MS and CNS Inflammatory Disease
Director(s):
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Program Speakers - Tentative

Start/End Time Title Faculty
2:35 PM - 3:00 PM Discussion Daniel Reich MD, PhD 

Disclosures

Speaker Disclosure
Daniel Reich, MD,PhD Vertex Pharmaceuticals. Support for a lab research project..

Abstract Presenters

Start Time Pub. Title Presenter
1:00 PM 001 Comparison of MRI Dissemination in Space Criteria for Predicting a First Clinical Event in Children with the Radiologically Isolated Syndrome Naila Makhani, MD
Disclosure:
Dr. Makhani has nothing to disclose.

1:12 PM 002 Longitudinal Assessment of Cervical Cord Atrophy Across MS Clinical Phenotypes: A Multicenter Study Maria A. Rocca
Disclosure:
Dr. Rocca has received personal compensation for activities with Novartis, Biogen Idec, Teva Neurosciences and Genzyme as a speaker.

1:24 PM 003 Atrophy of spinal cord gray matter is detectable at an early stage of multiple sclerosis Regina Schlaeger
Disclosure:
Dr. Schlaeger has nothing to disclose.

1:36 PM 004 Thalamic MRI and histopathologic correlations in advanced multiple sclerosis Kedar Mahajan
Disclosure:
Dr. Mahajan has nothing to disclose.

1:48 PM 005 In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis Tobias Granberg
Disclosure:
Dr. Granberg has nothing to disclose.

2:00 PM 006 Structural Connectivity Shapes Patterns of Cortical Atrophy in Multiple Sclerosis Kevin Patel, MD
Disclosure:
Dr. Patel has nothing to disclose.

2:12 PM 007 Prevalence of Leptomeningeal Contract Enhancement in Multiple Sclerosis Versus Other Chronic Neuroinflammatory Diseases Martina Absinta, MD
Disclosure:
Dr. Absinta has nothing to disclose.

2:24 PM 008 Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Post-Contrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis Deepa Ramasamy
Disclosure:
Dr. Zivadinov has received personal compensation for activities with EMD Serono, Genzyme, Novartis, for speaking and consultant fees. Dr. Zivadinov has received personal compensation in an editorial capacity for BioMed Research International, BMC Medicine, BMC Neurology, Clinical CNS Drugs, Conf Pap Neurosci, Journal of Alzheimer's Disease, Vein and Lymphatics, and Word J Surg Proc. Dr. Zivadinov has received research support from Biogen Idec, Claret Medical, Genzyme, Intekrin-Coherus, Novartis, and Teva Pharmaceuticals.

Register Now

Related Courses

Saturday April 21, 2018

9:30 AM-11:30 AM
C11 Treatment of Pediatric Multiple Sclerosis in the Current Era Brenda Banwell MD, FAAN

Sunday April 22, 2018

7:00 AM-9:00 AM
C33 Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making Aaron Miller MD, FAAN
3:30 PM-5:30 PM
C57 Spanish: Update on MS Therapy Lilyana Amezcua MD

Tuesday April 24, 2018

7:00 AM-9:00 AM
C97 Multiple Sclerosis Overview I: Clinical Pearls John Corboy MD, FAAN
1:00 PM-3:00 PM
C107 Multiple Sclerosis Overview II: Clinical Advances Scott Newsome DO, FAAN
3:30 PM-5:30 PM
C121 Multiple Sclerosis Overview III: Basic and Translational Science Michael Racke MD

Wednesday April 25, 2018

7:00 AM-9:00 AM
C135 Multiple Sclerosis Therapy: Disease-modifying Treatment I David Jones MD
9:15 AM-11:30 AM
PL5 Frontiers in Neuroscience Plenary Session
1:00 PM-3:00 PM
C146 Multiple Sclerosis Therapy: Disease-modifying Treatment II John Rose MD, FAAN
3:30 PM-5:30 PM
C161 Multiple Sclerosis Therapy: Symptom Management Jonathan Carter MD

Thursday April 26, 2018

7:00 AM-9:00 AM
C174 Clinical Pearls in Autoimmune Neurology: Real World Cases Stacey Clardy MD, PhD
1:00 PM-3:00 PM
N5 Neuroscience in the Clinic: Treatment of Progressive Multiple Sclerosis Eric Klawiter MD,
Ellen Mowry MD, FAAN

Friday April 27, 2018

1:00 PM-3:00 PM
C223 Neuromyelitis Optica Spectrum Disorders Dean Wingerchuk MD, FAAN

MEMBER LOG IN

Forgot Password?